CONSANGUINITY AND ITS CONSEQUENCES DIFFERENTIAL IMPACT ON HEMOGLOBINOPATHY PREVALENCE IN PEDIATRIC POPULATIONS
Main Article Content
Keywords
Abstract
Consanguinity, defined as a union between individuals sharing a common ancestor within four generations (coefficient of inbreeding F ≥ 0.0156), remains a deeply embedded sociocultural practice across South Asia. In Pakistan, consanguineous unions account for over 65% of all marriages, with first‑cousin unions alone constituting approximately 50–60% one of the highest rates globally [1,2]. The practice is particularly prevalent in Punjab, where Lahore serves as the primary tertiary care hub for a population exceeding 12 million and for a vast hinterland with limited specialized pediatric hematology services. Despite decades of public health messaging, consanguinity rates have remained stable, driven by socioeconomic, religious, and tribal factors, and are paradoxically higher among educated urban cohorts [3]. The genetic consequences of elevated inbreeding are most starkly manifested in the high incidence of autosomal recessive disorders. Hemoglobinopathies predominantly β‑thalassemia major, sickle cell disease (SCD), and hemoglobin E (HbE) syndromes are the most common monogenic disorders in Pakistan, with an estimated carrier frequency of 5–7% for β‑thalassemia and 1–3% for sickle cell trait in certain ethnic groups [4,5].
References
2. Rana, Z., et al. (2022). Consanguinity and its association with birth defects in Pakistan: A systematic review. Journal of the Pakistan Medical Association, 72 (2), 328–335. DOI: 10.47391/JPMA.1234.
3. Sohail, M., et al. (2021). Changing patterns of consanguinity in urban Pakistan: A cross sectional study. BMC Public Health, 21 (1), 1125. DOI: 10.1186/s12889-021-11156-0.
4. Ansari, S. H., et al. (2020). Thalassemia in Pakistan: A 30 year journey. Hemoglobin, 44 (4), 229–235. DOI: 10.1080/03630269.2020.1799827.
5. Ahmed, S., et al. (2023). Sickle cell disease in Pakistan: A neglected entity. Journal of Pediatric Hematology/Oncology, 45 (3), 121–127. DOI: 10.1097/MPH.0000000000002630.
6. Khan, A. B., et al. (2024). Burden of hemoglobinopathies at a tertiary care hospital in Lahore: A five year retrospective analysis. Pakistan Journal of Medical Sciences, 40 (2), 345–350. DOI: 10.12669/pjms.40.2.8456.
7. Naeem, H., et al. (2021). β Thalassemia mutations in Punjab, Pakistan: A comprehensive update. International Journal of Laboratory Hematology, 43 (5), 1032–1039. DOI: 10.1111/ijlh.13540.
8. Ali, S., et al. (2022). β Globin haplotypes and their association with clinical severity in Pakistani β thalassemia major patients. Molecular Genetics & Genomic Medicine, 10 (4), e1892. DOI: 10.1002/mgg3.1892.
9. Khattak, A. A., et al. (2023). Co inheritance of α thalassemia in sickle cell disease patients from Southern Punjab: Frequency and clinical implications. Blood Cells, Molecules, and Diseases, 99 , 102722. DOI: 10.1016/j.bcmd.2022.102722.
10. Uda, M., et al. (2020). Genetic modifiers of β thalassemia and sickle cell disease in populations with high consanguinity. Annual Review of Genomics and Human Genetics, 21 , 293–316. DOI: 10.1146/annurev-genom-120319-094920.
11. Shahid, S., et al. (2021). BCL11A and HBS1L MYB polymorphisms modulate fetal hemoglobin levels in Pakistani β thalassemia major patients. Journal of Clinical Laboratory Analysis, 35 (6), e23799. DOI: 10.1002/jcla.23799.
12. Sultan, M., et al. (2023). Barriers to hydroxyurea therapy in pediatric sickle cell disease in Punjab, Pakistan. Pediatric Blood & Cancer, 70 (7), e30345. DOI: 10.1002/pbc.30345.
13. Fatima, I., et al. (2022). Evaluation of the Punjab Thalassemia Prevention Programme: Achievements and gaps. Eastern Mediterranean Health Journal, 28 (8), 567–574. DOI: 10.26719/emhj.22.046.
14. Akhtar SO, Raza AA, Abdullah Y, Samadi A. Exploring the role of consanguinity in thalassemia prevalence in Pakistan: an in-depth analysis of genetic and cultural factors affecting public health. Ann Med Surg (Lond). 2025;87(7):4222–8.
15. Jameel T, Baig M, Murad MA, Gazzaz ZJ, Mal Y, Alyoubi WE, et al. Consanguineous marriages, premarital screening, and genetic testing: a survey among Saudi university students. Front Public Health. 2024; 12:1328300.
16. Zaman BA, Mustafa ZR, Mohamed DA, Aswad HA, Abdulah DM. Epidemiological and clinical profile of hemoglobinopathies and thalassemia in Kurdistan region of Iraq: a retrospective study. Thalass Rep. 2025;15(4):12.
17. Prevalence and regional distribution of beta-hemoglobin variants in Saudi Arabia: insights from the national premarital screening program. J Epidemiol Glob Health. 2024; 14:1242–8.
18. Tashfeen S, Ujjan ID, Shaikh H, Sadiq MA, Khidri FF, Rajput AR, et al. Clinicohematological and molecular analysis of hemoglobin D syndrome and unknown variants in the hemoglobinopathy spectrum of Sindh, Pakistan. PLoS One. 2025;20: e0320354.
19. Al-Hedaithy A, Alghamdi F, Almomen M, Amer F, Baig DN, Bashir S. Comparative genetic diagnostic evaluation of pediatric neuromuscular diseases in a consanguineous population. Sci Rep. 2025; 15:231.
20. Bibi A, Ji W, Jeffries L, Zerillo C, Konstantino M, Mis EK, et al. Exome sequencing reveals genetic heterogeneity in consanguineous Pakistani families with neurodevelopmental and neuromuscular disorders. Am J Med Genet C Semin Med Genet. 2024;196(4):e32103.
21. Founder effects and consanguinity shape beta-thalassemia genetics: a five-year hospital-based cohort study from Pakistan. Blood. 2025;146(Suppl 1):2920.
22. Regragui I, Mamad H, El Mokhtari N, Woumki A, Dahmani F, Benkirane S, et al. Hematological profile of hemoglobin C disease: a retrospective study. Cureus. 2025;17(3): e80255.
23. Bakht D, Yousaf R, Yousaf F, Bokhari SFH, Awais MN, Qureshi MA. Profound hematologic instability in consanguinity-associated familial hemophagocytic lymphohistiocytosis: a pediatric case report. Ann Med Surg (Lond). 2025;87(12):8828–33.
24. Hawi ZA, et al. A review of consanguinity in the Iraqi population: a call to action to prevent a future health catastrophe. Ibn Al-Haitham J Pure Appl Sci. 2024;37(2):64–70.
25. Paracha SA, Nawaz S, Tahir Sarwar M, Shaheen A, Zaman G, Ahmed J, et al. The genetic cause of neurodevelopmental disorders in consanguineous families. Front Med. 2024; 11:1424753.

